Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment.

Helicobacter pylori early gastric cancer endoscopic submucosal dissection gastric cancer upper endoscopy

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
25 01 2023
Historique:
received: 24 12 2022
revised: 22 01 2023
accepted: 23 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Gastric cancer (GC) is a relevant public health issue as its incidence and mortality rates are growing worldwide. There are recognized carcinogen agents, such as obesity, tobacco, meat, alcohol consumption and some dietary protective factors. Strategies of early diagnosis through population-based surveillance programs have been demonstrated to be effective in lowering the morbidity and mortality related to GC in some countries. Indeed, the detection of early lesions is very important in order to offer minimally invasive treatments. Endoscopic resection is the gold standard for lesions with a low risk of lymph node metastasis, whereas surgical mini-invasive approaches can be considered in early lesions when endoscopy is not curative. This review outlines the role of lifestyle and prevention strategies for GC, in order to reduce the patients' risk factors, implement the surveillance of precancerous conditions and, therefore, improve the diagnosis of early lesions. Furthermore, we summarize the available treatments for early gastric cancer.

Identifiants

pubmed: 36767516
pii: ijerph20032149
doi: 10.3390/ijerph20032149
pmc: PMC9916026
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Eur J Cancer Prev. 2018 Mar;27(2):124-133
pubmed: 27560662
Int J Cancer. 2020 Jul 1;147(1):45-55
pubmed: 31584199
J Enzyme Inhib Med Chem. 2016;31(sup2):46-50
pubmed: 27233102
Gastroenterology. 2011 Dec;141(6):2017-2025.e3
pubmed: 21856268
Eur J Cancer. 2009 Nov;45(16):2867-73
pubmed: 19427197
Chem Biol Interact. 2021 Feb 25;336:109365
pubmed: 33412155
Eur J Gastroenterol Hepatol. 2012 Jan;24(1):37-41
pubmed: 21989121
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
BMJ Open. 2019 Dec 23;9(12):e025803
pubmed: 31874864
Int J Vitam Nutr Res. 2008 May;78(3):121-8
pubmed: 19003734
Front Oncol. 2019 Aug 07;9:725
pubmed: 31440467
Ann N Y Acad Sci. 2012 Oct;1271:37-43
pubmed: 23050962
PLoS One. 2014 Oct 14;9(10):e109783
pubmed: 25314140
Aliment Pharmacol Ther. 2002 Jul;16(7):1249-59
pubmed: 12144574
BMC Med. 2020 Sep 14;18(1):257
pubmed: 32921305
Lancet Oncol. 2002 Sep;3(9):565-74
pubmed: 12217794
Gut. 2016 Jun;65(6):914-24
pubmed: 25800782
Cancers (Basel). 2022 Oct 06;14(19):
pubmed: 36230809
Nutrients. 2019 Apr 11;11(4):
pubmed: 30979076
Inflamm Intest Dis. 2016 Oct;1(3):123-128
pubmed: 29922667
Gut. 2013 Sep;62(9):1270-9
pubmed: 22773549
Helicobacter. 2017 Oct;22(5):
pubmed: 28771894
Dig Endosc. 2016 Jan;28(1):3-15
pubmed: 26234303
Eur J Epidemiol. 2010 Jul;25(7):439-48
pubmed: 20585973
Dig Dis Sci. 2003 Mar;48(3):475-85
pubmed: 12757158
Front Oncol. 2022 Jul 12;12:939244
pubmed: 35903707
Surg Endosc. 2011 Aug;25(8):2666-77
pubmed: 21424201
Biomed Res Int. 2018 Jan 11;2018:3152346
pubmed: 29568748
J Formos Med Assoc. 2022 Dec;121(12):2378-2392
pubmed: 36085264
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Oncotarget. 2017 Jan 17;8(3):4781-4795
pubmed: 27902474
Aliment Pharmacol Ther. 2011 Jun;33(12):1361-9
pubmed: 21492197
Sci Rep. 2020 Apr 21;10(1):6680
pubmed: 32317659
Lancet. 2009 Apr 11;373(9671):1301-9
pubmed: 19328542
Cancer Causes Control. 2016 Jul;27(7):837-51
pubmed: 27153845
Gastrointest Endosc. 2011 May;73(5):917-27
pubmed: 21316050
Surg Endosc. 2022 Dec 19;:
pubmed: 36536083
Cancer Res Treat. 2022 Jul;54(3):842-849
pubmed: 34607395
Digestion. 2022;103(1):76-82
pubmed: 34736250
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2427-34
pubmed: 17164366
Int J Cancer. 2018 Oct 1;143(7):1671-1677
pubmed: 29707766
World J Surg Oncol. 2020 Jul 8;18(1):160
pubmed: 32641052
Cancer Med. 2022 Feb;11(4):1217-1231
pubmed: 34970858
Frontline Gastroenterol. 2020 Jul 30;12(4):322-331
pubmed: 34249318
Gastric Cancer. 2018 Jul;21(4):579-587
pubmed: 29460004
Tumour Biol. 2016 Aug;37(8):11365-74
pubmed: 26960693
J Physiol. 2018 Sep;596(17):3861-3867
pubmed: 29427515
Endoscopy. 2019 Apr;51(4):365-388
pubmed: 30841008
Endoscopy. 2016 Sep;48(9):843-64
pubmed: 27548885
Cancer Causes Control. 2010 Feb;21(2):237-42
pubmed: 19856118
Helicobacter. 2020 Oct;25(5):e12727
pubmed: 32700438
World J Gastroenterol. 2016 Jul 7;22(25):5694-717
pubmed: 27433084
Clin Cancer Res. 2017 May 15;23(10):2391-2399
pubmed: 28143873
Mol Cancer Ther. 2009 Nov;8(11):3046-55
pubmed: 19887546
Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):9-17
pubmed: 33639688
Front Oncol. 2022 Jul 22;12:855216
pubmed: 35936695
Int J Cancer. 2019 Jun 15;144(12):2936-2944
pubmed: 30521095
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
Proc Nutr Soc. 2004 Feb;63(1):49-63
pubmed: 15099407
PLoS One. 2012;7(11):e50041
pubmed: 23209638
Cancers (Basel). 2022 Jul 24;14(15):
pubmed: 35892861
Medicine (Baltimore). 2019 May;98(19):e15663
pubmed: 31083268
Medicine (Baltimore). 2016 Jul;95(27):e3986
pubmed: 27399073
Jpn J Clin Oncol. 2018 Jul 01;48(7):673-683
pubmed: 29889263
Endoscopy. 2022 Jun;54(6):591-622
pubmed: 35523224
Ann Surg Oncol. 2012 May;19(5):1541-50
pubmed: 22048632
Cancer Sci. 2007 Jul;98(7):1120-7
pubmed: 17459059
Cancer. 2003 Sep 1;98(5):940-8
pubmed: 12942560
World J Gastroenterol. 2014 Aug 14;20(30):10432-9
pubmed: 25132759
Sci Rep. 2020 Feb 21;10(1):3161
pubmed: 32081926
Gut. 2020 Dec;69(12):2113-2121
pubmed: 32205420
Dig Endosc. 2016 May;28(4):379-393
pubmed: 26896760
World J Gastroenterol. 2022 Apr 21;28(15):1548-1562
pubmed: 35582127
J Cell Physiol. 2020 Apr;235(4):3189-3206
pubmed: 31595495

Auteurs

Clara Benedetta Conti (CB)

Interventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Stefano Agnesi (S)

Department of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.

Miki Scaravaglio (M)

Interventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Pietro Masseria (P)

Department of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.

Marco Emilio Dinelli (ME)

Interventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Massimo Oldani (M)

General Surgery Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Fabio Uggeri (F)

Department of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH